These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1713245)

  • 21. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
    Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC
    J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW
    Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
    Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
    Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia.
    Richard P; Beucler I; Pascual De Zulueta M; Biteau N; De Gennes JL; Iron A
    Clin Sci (Lond); 1997 Jul; 93(1):89-95. PubMed ID: 9279208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
    Miller DB; Hegele RA; Wolfe BM; Huff MW
    J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.
    Ordovas JM; Litwack-Klein L; Wilson PW; Schaefer MM; Schaefer EJ
    J Lipid Res; 1987 Apr; 28(4):371-80. PubMed ID: 3585172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ApoB-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apoB gene and hypobetalipoproteinemia.
    Wagner RD; Krul ES; Tang J; Parhofer KG; Garlock K; Talmud P; Schonfeld G
    J Lipid Res; 1991 Jun; 32(6):1001-11. PubMed ID: 1940616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
    Schmitz G; Assmann G; Augustin J; Dirkes-Kersting A; Brennhaüsen B; Karoff C
    J Lipid Res; 1985 Mar; 26(3):316-26. PubMed ID: 3989390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
    J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophoretic analysis of oxidative modification of apolipoprotein E in very low density lipoprotein from fresh human plasma.
    Kashiwagi S; Nakamura K; Arai H; Yamashita H; Ito H
    Electrophoresis; 1999 Jun; 20(7):1418-24. PubMed ID: 10424464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa.
    Talmud PJ; Converse C; Krul E; Huq L; McIlwaine GG; Series JJ; Boyd P; Schonfeld G; Dunning A; Humphries S
    Clin Genet; 1992 Aug; 42(2):62-70. PubMed ID: 1424233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
    Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins.
    Dong LM; Weisgraber KH
    J Biol Chem; 1996 Aug; 271(32):19053-7. PubMed ID: 8702576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function.
    Krul ES; Tikkanen MJ; Schonfeld G
    J Lipid Res; 1988 Oct; 29(10):1309-25. PubMed ID: 2466929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.
    Dong LM; Wilson C; Wardell MR; Simmons T; Mahley RW; Weisgraber KH; Agard DA
    J Biol Chem; 1994 Sep; 269(35):22358-65. PubMed ID: 8071364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
    Kobayashi J; Shirai K; Murano T; Misawa Y; Tashiro J; Yoshida T; Shinomiya M
    Biochim Biophys Acta; 2002 Jun; 1583(1):117-21. PubMed ID: 12069856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.